# Anixa Biosciences Inc: Form 8-K, filed Mar 21, 2025

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: 8-K
- Filed: 2025-03-21
- Accepted by EDGAR: Mar 21, 2025, 16:15 ET
- Period: 2025-03-20
- Accession: 0001493152-25-011151
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315225011151/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315225011151/

## Items reported

- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315225011151/form8-k.htm

Filed Mar 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-011151. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.
